HANYWIL DARK SPOT

Manufacturer
Jiashen International Trade Limited
Effective date
2024-11-22
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:38:38

Label at a glance#

ProductHANYWIL DARK SPOT
Active ingredientNIACINAMIDE, ALOE BARBADENSIS FLOWER EXTRACT, SOPHORA FLAVESCENS ROOT, INOSITOL, CHRYSANTHELLUM INDICUM TOP
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

NIACINAMIDE
INOSITOL
Chrysanthellum Indicum Extract
Aloe Barbadensis Extract
Sophora Angustifolia Root Extract

INACTIVE INGREDIENT SECTION

WATER
GLYCERIN
PROPYLENE GLYCOL
CAPRYLIC/CAPRIC TRIGLYCERIDE
CETEARYL ALCOHOL
CETEARYL GLUCOSIDE
DIMETHICONE
BUTYROSPERMUM PARKII (SHEA) BUTTER
GLYCERYL STEARATE
PORTULACA OLERACEA EXTRAC
CHRYSANTHELLUM INDICUM EXTRACT
PELARGONIUM GRAVEOLENS EXTRACT
MENTHA ARVENSIS LEAF EXTRACT
ALOE BARBADENSIS EXTRACT
SOPHORA ANGUSTIFOLIA ROOT EXTRACT
SQUALANE
TOCOPHERYL ACETATE
1,2-HEXANEDIOL
HYDROXYACETOPHENONE
PHENOXYETHANOL
ETHYLHEXYLGLYCERIN
CARBOMER
DISODIUM EDTA
FRAGRANCE

OTC - PURPOSE SECTION

DARK SPOTCORRECTINGSERUMENRICHED WITHNATURAL PLANTEXTRACTS,EFFECTIVELYFADESDARK SPOTSBRIGHTENS ANDEVENSSKIN TONE.

WARNINGS SECTION

Ask a doctor before use if you have
WarningsFor extemmal use only,. Before using,test forsensitivity on a smallarea of skin. Do not use ondamaged skin. Avoid contact with eves
Skin sensitization.
Skin plastic surgery

OTC - STOP USE SECTION

If pregnant or breast-feading, ask a health
professional before use. Keep out of reach of
children. In case of overdose,got medical help
or contact a Poison Control Center right away.

OTC - DO NOT USE SECTION

For external use only. Before using,test for
sensitivity on a small area of skin. Do not use on
damaged skin. Avoid contact with eyes.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of
children. In case of overdose,got medical help
or contact a Poison Control Center right away.

OTC - WHEN USING SECTION

Directions:
After cleansing,gentty press thepump to dispensean appropriate
amount of serum.
Use the roller ball
applicator to evenly
appty the serum tothe face and neck.Massage until fullyabsorbed.Usetwicedaily for best results

INDICATIONS & USAGE SECTION

Directions:
After cleansing,gentty press thepump to dispensean appropriate
amount of serum.
Use the roller ball
applicator to evenly
appty the serum tothe face and neck.Massage until fullyabsorbed.Usetwicedaily for best results

DOSAGE & ADMINISTRATION SECTION

Step 2: Take an appropriateamount of dark spotcream and applyevenly to the desiredarea, massage gentlyfor 1-2 minutes.Step 3: Use twice aday, with massage tohelp absorption,adhere to the use ofmore than a month thebest results.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dark spot C-PACKAGEDark spot C-PACKAGE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84867-004-01HANYWIL DARK SPOT15 mL in 1 BOTTLE, PUMPSOLUTION, GEL FORMING / DROPS152

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84867-004HANYWIL DARK SPOT SOLUTION, GEL FORMING / DROPS [JIASHEN INTERNATIONAL TRADE LIMITED]21 package rows20241123_268fb96b-86c6-11a8-e063-6394a90abc34.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 28 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84867-00484867-004-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 27 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
277d7fb1-edce-7888-e063-6394a90a74f8268fb96b-86c6-11a8-e063-6394a90abc342024-11-22WarningsExact identifier
spl id: 277d7fb1-edce-7888-e063-6394a90a74f8
spl set id: 268fb96b-86c6-11a8-e063-6394a90abc34

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.